Teladoc Health, Inc. reported its financial results for the second quarter ended June 30, 2025, with total revenue decreasing 1.6% year-over-year to $631.9 million. The net loss significantly improved to $32.7 million, or $0.19 per share, compared to $837.7 million, or $4.92 per share, in Q2 2024, which included a substantial goodwill impairment charge.
The Integrated Care segment's revenue increased 3.7% to $391.5 million, with U.S. Integrated Care membership reaching 102.4 million, an 11% increase year-over-year. However, the BetterHelp segment's revenue decreased 9.0% to $240.4 million, and average monthly paying users declined 5% to 0.39 million.
In July 2025, Teladoc secured a new $300 million revolving credit facility, enhancing its financial flexibility. The company reaffirmed its full-year 2025 free cash flow guidance of $170 million to $200 million, despite narrowing its consolidated revenue guidance to $2.501 billion to $2.548 billion.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.